4//SEC Filing
Kalkofen Donald A. 4
Accession 0001104659-22-024841
CIK 0001377121other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:26 PM ET
Size
7.4 KB
Accession
0001104659-22-024841
Insider Transaction Report
Form 4
Kalkofen Donald A.
Chief Financial Officer
Transactions
- Award
Common Stock
2022-02-15+7,500→ 18,521 total - Award
Stock Option (right to buy)
2022-02-15+45,000→ 45,000 totalExercise: $28.73Exp: 2032-02-14→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on February 15, 2023, 2024 and 2025.
- [F2]Includes an aggregate of 635 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021.
- [F3]The stock option vests in 48 equal monthly installments following the date of grant.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001771066
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 7:26 PM ET
- Size
- 7.4 KB